Creatine as a therapeutic strategy for myopathies (Q37852586)

24 August 2017

1 reference

title

Creatine as a therapeutic strategy for myopathies (English)

1 reference

24 August 2017

M A Tarnopolsky

1

1 reference

24 August 2017

publication date

12 March 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

40

1 reference

24 August 2017

issue

5

1 reference

24 August 2017

page(s)

1397-1407

1 reference

Exercise: an important component of treatment in the idiopathic inflammatory myopathies

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Creatine monohydrate increases bone mineral density in young Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Sporadic inclusion body myositis: pilot study on the effects of a home exercise program on muscle function, histopathology and inflammatory reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Targeting cellular energy production in neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Effects of oral creatine supplementation in a patient with MELAS phenotype and associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Deflazacort treatment of Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Effect of alpha-lipoic acid combined with creatine monohydrate on human skeletal muscle creatine and phosphagen concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Creatine intake attenuates corticosteroid-induced impairment of voluntary running in hamsters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Creatine supplementation combined with resistance training in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Dietary creatine monohydrate supplementation increases satellite cell mitotic activity during compensatory hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Alendronate in the treatment of low bone mass in steroid-treated boys with Duchennes muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Opposite actions of caffeine and creatine on muscle relaxation time in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

A placebo-controlled crossover trial of creatine in mitochondrial diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Effectiveness of creatine monohydrate in mitochondrial encephalomyopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Striking improvement of muscle strength under creatine therapy in a patient with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Direct antioxidant properties of creatine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Beneficial effects of creatine supplementation in dystrophic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Effect of creatine supplementation on skeletal muscle of mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Upregulation of the creatine synthetic pathway in skeletal muscles of mature mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Resistance training in patients with single, large-scale deletions of mitochondrial DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Creatine supplementation augments the increase in satellite cell and myonuclei number in human skeletal muscle induced by strength training

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Nutritional therapy improves function and complements corticosteroid intervention in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Increased PFK activity and GLUT4 protein content in McArdle's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Dietary supplementation with creatine monohydrate prevents corticosteroid-induced attenuation of growth in young rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Creatine monohydrate in DM2/PROMM: a double-blind placebo-controlled clinical study. Proximal myotonic myopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Activation of muscle glycolysis: a role for creatine phosphate in phosphofructokinase regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

The mitochondrial cocktail: rationale for combined nutraceutical therapy in mitochondrial cytopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Creatine monohydrate increases strength in patients with neuromuscular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Mitochondrial myopathies: diagnosis, exercise intolerance, and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Creatine transporter and mitochondrial creatine kinase protein content in myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Attenuation of free radical production and paracrystalline inclusions by creatine supplementation in a patient with a novel cytochrome b mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Creatine monohydrate and conjugated linoleic acid improve strength and body composition following resistance exercise in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Metabolic myopathies: update 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Creatine monohydrate in myotonic dystrophy: a double-blind, placebo-controlled clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

Creatine supplementation improves intracellular Ca2+ handling and survival in mdx skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0876-4

10.1007/S00726-011-0876-4

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference